Myocardial reinfarction. Considerations on secondary prevention
Mazza, F.; Messore, T.; Contiello, V.; Ciappa, G.; Caropreso, M.R.; Petrillo, T.; Ucciero, R.
Minerva Cardioangiologica 33(6): 325-328
1985
ISSN/ISBN: 0026-4725 PMID: 2864662 Document Number: 243318
Document emailed within 1 workday
Related Documents
Burkart, F. 1985: Prevention of myocardial infarct and of reinfarction Therapeutische Umschau. Revue Therapeutique 42(8): 511-520Flaker, G.C.; Singh, V.N. 1993: Prevention of myocardial reinfarction. Recommendations based on results of drug trials Postgraduate Medicine 94(6): 94
Nightingale, A.; Marshall, A. 1998: Secondary prevention in acute myocardial infarction. Long term insulin treatment is important in secondary prevention in diabetic patients Bmj 317(7166): 1153
Leickert, K.H. 1982: Coumarin derivatives in the prevention of reinfarction Die Medizinische Welt 33(50): 1832-1833
Bergstrand, R.; Elmfeldt, D.; Hjalmarson, A.; Vedin, J.A.; Wilhelmsen, L.; Wilhelmsson, C. 1978: Secondary prevention after myocardial infarction Lakartidningen 75(20): 2038-2044
Degeorges, M.; Boissel, J.P.; Guermonprez, J.L.; Sultan, Y.; Weber, S. 1981: Prevention of secondary myocardial infarction La Semaine des Hopitaux: Organe Fonde Par l'Association d'Enseignement Medical des Hopitaux de Paris 57(39-40): 1623-1625
Follath, F. 1986: Secondary prevention following myocardial infarct Schweizerische Rundschau für Medizin Praxis 75(40): 1177-1180
Mehta, R.H.; Eagle, K.A. 1998: Secondary prevention in acute myocardial infarction Bmj 316(7134): 838-842
Wilhelmsen, L. 1988: ISIS-2--a study of patients with myocardial infarction. a combination of streptokinase and acetylsalicylic acid diminishes mortality risk, reinfarction and stroke Lakartidningen 85(35): 2759-2764
Bocková, E.; Polácková, J. 1985: Behavior pattern in the secondary prevention of myocardial infarct Ceskoslovenska Psychiatrie 81(2): 96-99
Deedwania, P.C.; Carbajal, E.V. 1993: Secondary prevention after myocardial infarction. Too many choices, which ones work? Archives of Internal Medicine 153(3): 285-288
Einecke, D. 2011: Secondary prevention. Pills without co-pay reduce complications after myocardial infarct MMW Fortschritte der Medizin 153(48): 15
Taylor, S.H. 1996: Secondary prevention of myocardial infarction: new horizons for pharmacotherapy. Introduction European Heart Journal 17 Suppl F: 1-2
Paragh, G.; Balogh, Z.; Boda, J.; Mohácsi, A.; Kovács, P.; Polgár, P.; Wórum, F.; Kakuk, G. 1997: Lipid lowering treatment in secondary prevention following myocardial infarct Orvosi Hetilap 138(29): 1849-1853
de Jonge, F.A.; Jonker, J.J. 1983: New study on the secondary prevention of myocardial infarct using oral anticoagulants Nederlands Tijdschrift Voor Geneeskunde 127(31): 1391-1394
Schilling, J.; Schwendinger, M.; Vranjes, N.; Gutzwiller, F. 1996: Thrombolysis following myocardial infarct. European Secondary Prevention Study Praxis 85(42): 1311-1315
Smith, J.; Channer, K.S. 1995: Increasing prescription of drugs for secondary prevention after myocardial infarction Bmj 311(7010): 917-918
Di Pasquale, G.; Ottani, F.; Ceré, E.; Biancoli, S.; Sassone, B.; Lombardi, A. 1998: Platelet antiaggregants or anticoagulants in the secondary prevention after myocardial infarct Recenti Progressi in Medicina 89(10): 514-519
Schubert, W. 1972: Influence of long-term anticoagulant treatment on reinfarction, mortality and rehabilitation of patients with myocardial infarct. 4-year-observation ambulatory surveillance of infarction Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 27(7): 307-311
Sárosi, I.; Debreceni, G.; Mühl, D.; Kónyi, A.; Bogár, L.; Tekeres, M.; Tóth, K.; Habon, T.; Czopf, L.; Zámbó, K.; Schmidt, E. 1997: Comparative study of verapamil and bisoprolol in the secondary prevention of myocardial infarction Orvosi Hetilap 138(31): 1939-1945